ORKA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Oruka Therapeutics, Inc.

NASDAQ | ORKA

16.04

USD

$0.00

(

0.00%

)

At Close (As of Sep 18, 2025)

$558.02M

Market Cap

-

P/E Ratio

-

EPS

$31.13

52 Week High

$5.49

52 Week Low

HEALTHCARE

Sector

ORKA Chart

Recent Chart
Price Action

ORKA Technicals

Tags:

ORKA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (None)
Gross Profit -$27K
Total Revenue -
Cost Of Revenue $27K
Costof Goods And Services Sold $27K
Operating Income -$88M
Selling General And Administrative -
Research And Development $75M
Operating Expenses $88M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense $1.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $27K
Income Before Tax -$84M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -
Comprehensive Income Net Of Tax -
Ebit -$82M
Ebitda -$82M
Net Income -$84M

Revenue & Profitability

Earnings Performance

ORKA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $396M
Total Current Assets $377M
Cash And Cash Equivalents At Carrying Value $62M
Cash And Short Term Investments $62M
Inventory -
Current Net Receivables -
Total Non Current Assets $19M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $18M
Short Term Investments $314M
Other Current Assets $1.2M
Other Non Current Assets -
Total Liabilities $14M
Total Current Liabilities $13M
Current Accounts Payable $3.5M
Deferred Revenue -
Current Debt -
Short Term Debt $213K
Total Non Current Liabilities $755K
Capital Lease Obligations $968K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $968K
Other Current Liabilities $9.4M
Other Non Current Liabilities -
Total Shareholder Equity $382M
Treasury Stock -
Retained Earnings -$84M
Common Stock $37K
Common Stock Shares Outstanding $17M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (None)
Operating Cashflow -$58M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $27K
Capital Expenditures $189K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$330M
Cashflow From Financing $450M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$84M

yearly Income Statement (As of Dec 31, 2024)

Field Value (None)
Gross Profit -$27K
Total Revenue -
Cost Of Revenue $27K
Costof Goods And Services Sold $27K
Operating Income -$88M
Selling General And Administrative -
Research And Development $75M
Operating Expenses $88M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense $1.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $27K
Income Before Tax -$84M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -
Comprehensive Income Net Of Tax -
Ebit -$82M
Ebitda -$82M
Net Income -$84M

Dividends

Field Value
Ex Dividend Date 2024-08-29
Declaration Date 2024-08-16
Record Date 2024-08-26
Payment Date 2024-08-28
Amount 1.613

ORKA Profile

Oruka Therapeutics, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Oruka Therapeutics, Inc. is an innovative biotechnology firm focused on developing cutting-edge therapies to address unmet medical needs in various disease areas. Leveraging advanced research and development capabilities, the company aims to bring transformative treatments to market, primarily targeting chronic and complex conditions. With a commitment to scientific excellence and a strong pipeline of product candidates, Oruka Therapeutics stands poised to make a significant impact in the healthcare sector while delivering value to its stakeholders.

INTC
+28.93%
$32.10
DVLT
+16.60%
$0.39
CGBS
-39.47%
$0.03
SNAP
+3.23%
$7.99
AERT
+58.84%
$0.90
ADAP
+27.84%
$0.10
GPUS
+28.56%
$0.52
APVO
+37.48%
$1.93
BITF
+11.31%
$3.39
ATCH
-3.39%
$1.56
NEHC
-4.00%
$0.45
NVDA
+2.92%
$175.27
TPIC
-45.91%
$0.12
PLUG
+4.49%
$2.08
AXDX
-61.36%
$0.03
CDLX
+64.40%
$2.35
ETNB
+85.21%
$14.96
LASE
+33.52%
$3.73
RGTI
+16.16%
$25.54
LYT
-16.77%
$0.09
GRAB
+3.34%
$6.30
KDLY
-4.66%
$1.43
AMD
-3.10%
$154.22
CJET
+2.15%
$0.09
MULN
-6.96%
$0.06
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
TSLA
-0.25%
$424.76
AAL
+0.76%
$12.57
QBTS
+4.79%
$23.62
ADD
-25.47%
$0.05
BMNR
+6.16%
$60.59
SRM
+53.27%
$10.30
NIO
-0.06%
$7.44
BINI
-15.47%
$0.05
SOUN
+1.71%
$15.37
PLTR
+3.67%
$174.52
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
NFE
+14.87%
$2.48
RAYA
-4.69%
$0.04
RR
+10.73%
$4.40
ETWO
0.00%
$3.30
CLSK
+13.25%
$12.95
MARA
+6.63%
$18.48
QS
+11.20%
$11.41
AFMD
-34.94%
$0.18
PBM
+32.25%
$4.92
NVNI
+22.95%
$0.98
SMCI
-0.02%
$44.90
QUBT
+3.67%
$18.36
BEEM
+18.47%
$2.99
BURU
+0.14%
$0.13
IXHL
+1.25%
$0.53
IONQ
+7.02%
$70.04
DNN
-1.18%
$2.50
F
+0.08%
$11.67
AQB
+17.98%
$1.34
SOFI
+1.30%
$27.49
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
CDE
-1.65%
$16.00
BCDA
-23.12%
$1.18
BBD
-1.20%
$3.27
ONDS
+2.66%
$6.26
BTG
-0.92%
$4.29
HOOD
+3.04%
$122.24
LDI
-11.73%
$4.02
AMZN
+0.25%
$232.21
CIFR
-4.02%
$11.88
QSI
+24.20%
$1.56
AAPL
-0.26%
$238.34
SBET
+6.69%
$18.26
LAWR
+37.17%
$2.77
IONZ
-10.18%
$4.31
RCAT
-7.41%
$10.43
UEC
-5.59%
$11.55
RXRX
+4.03%
$4.89
NOK
+1.06%
$4.75
ACHR
+2.16%
$9.19
ORIS
+9.67%
$0.15
OPI
-34.61%
$0.37
ZAPP
-46.30%
$0.15
GOOGL
+0.27%
$250.20
ADGM
-3.68%
$1.57
AIRE
-4.00%
$1.19
NVO
+6.30%
$61.87
NAKA
-1.04%
$1.41
JOBY
+2.66%
$14.53
CAN
+1.86%
$0.82
ORBS
+21.59%
$13.20
BTBT
+4.45%
$3.16
YAAS
-6.49%
$0.06
TLRY
+2.52%
$1.22
REPL
-41.94%
$3.31
ORCL
-0.48%
$299.95
ABEV
-0.84%
$2.34
BABA
-2.29%
$162.36
RZLV
-1.64%
$6.99
INTC
+28.93%
$32.10
DVLT
+16.60%
$0.39
CGBS
-39.47%
$0.03
SNAP
+3.23%
$7.99
AERT
+58.84%
$0.90
ADAP
+27.84%
$0.10
GPUS
+28.56%
$0.52
APVO
+37.48%
$1.93
BITF
+11.31%
$3.39
ATCH
-3.39%
$1.56
NEHC
-4.00%
$0.45
NVDA
+2.92%
$175.27
TPIC
-45.91%
$0.12
PLUG
+4.49%
$2.08
AXDX
-61.36%
$0.03
CDLX
+64.40%
$2.35
ETNB
+85.21%
$14.96
LASE
+33.52%
$3.73
RGTI
+16.16%
$25.54
LYT
-16.77%
$0.09
GRAB
+3.34%
$6.30
KDLY
-4.66%
$1.43
AMD
-3.10%
$154.22
CJET
+2.15%
$0.09
MULN
-6.96%
$0.06
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
TSLA
-0.25%
$424.76
AAL
+0.76%
$12.57
QBTS
+4.79%
$23.62
ADD
-25.47%
$0.05
BMNR
+6.16%
$60.59
SRM
+53.27%
$10.30
NIO
-0.06%
$7.44
BINI
-15.47%
$0.05
SOUN
+1.71%
$15.37
PLTR
+3.67%
$174.52
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
NFE
+14.87%
$2.48
RAYA
-4.69%
$0.04
RR
+10.73%
$4.40
ETWO
0.00%
$3.30
CLSK
+13.25%
$12.95
MARA
+6.63%
$18.48
QS
+11.20%
$11.41
AFMD
-34.94%
$0.18
PBM
+32.25%
$4.92
NVNI
+22.95%
$0.98
SMCI
-0.02%
$44.90
QUBT
+3.67%
$18.36
BEEM
+18.47%
$2.99
BURU
+0.14%
$0.13
IXHL
+1.25%
$0.53
IONQ
+7.02%
$70.04
DNN
-1.18%
$2.50
F
+0.08%
$11.67
AQB
+17.98%
$1.34
SOFI
+1.30%
$27.49
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
CDE
-1.65%
$16.00
BCDA
-23.12%
$1.18
BBD
-1.20%
$3.27
ONDS
+2.66%
$6.26
BTG
-0.92%
$4.29
HOOD
+3.04%
$122.24
LDI
-11.73%
$4.02
AMZN
+0.25%
$232.21
CIFR
-4.02%
$11.88
QSI
+24.20%
$1.56
AAPL
-0.26%
$238.34
SBET
+6.69%
$18.26
LAWR
+37.17%
$2.77
IONZ
-10.18%
$4.31
RCAT
-7.41%
$10.43
UEC
-5.59%
$11.55
RXRX
+4.03%
$4.89
NOK
+1.06%
$4.75
ACHR
+2.16%
$9.19
ORIS
+9.67%
$0.15
OPI
-34.61%
$0.37
ZAPP
-46.30%
$0.15
GOOGL
+0.27%
$250.20
ADGM
-3.68%
$1.57
AIRE
-4.00%
$1.19
NVO
+6.30%
$61.87
NAKA
-1.04%
$1.41
JOBY
+2.66%
$14.53
CAN
+1.86%
$0.82
ORBS
+21.59%
$13.20
BTBT
+4.45%
$3.16
YAAS
-6.49%
$0.06
TLRY
+2.52%
$1.22
REPL
-41.94%
$3.31
ORCL
-0.48%
$299.95
ABEV
-0.84%
$2.34
BABA
-2.29%
$162.36
RZLV
-1.64%
$6.99
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.